The Australian Diabetes Society is proud to host the ADS Diabetes Technology Workshop which will be held over 1.5 days on Saturday 28 & Sunday 29 October 2023 in Melbourne at the Crowne Plaza Hotel. The workshop is primarily open to clinicians who consult and manage people living with type 1 diabetes. The aim of the workshop is to provide […]
Live Panel Discussion Join our panel of experts on Monday, 13 November 2023 from 7:00 pm to 8:00 pm (AEDT) as they discuss the outcomes of the American Heart Association (AHA) Scientific Sessions 2023 in relation to the advancements in managing cardiovascular disease in people living with obesity. We will be reviewing trial results presented […]
Join us on Thursday, 23 November 2023 from 7:00 pm to 8:00 pm (AEDT) as we discuss the following in relation to the role of SGLT2 inhibitors in type 2 diabetes: The benefits of SGLT2i on glycaemia, CVD and CLD The benefits of early glycaemic management of type 2 diabetes Addressing the barriers for SGLT2i […]
The Australian Diabetes Society is running its annual Practical Skills Course for First Year Trainees in Adult Endocrinology over two days with the first day held on Saturday 17th February 2024 from 8.00am to 6.15pm (AEDT) at the Crowne Plaza Hotel in Melbourne. The second day will be held as an online virtual event on Saturday 15th June 2024 from 9.30am to 5.15pm (AEST). The two-day course will focus […]
The Australian Islet Study Group (AISG) Meeting is the premier meeting for researchers interested in all aspects of islet and beta cell function; including secretion pathway mechanisms, islet structure and function, morphology, in vitro and in vivo models, omics and big data considerations. We invite you to attend this exciting annual meeting discussing islet biology […]
Live Panel Discussion The use of GLP-1 agonists are revolutionising the care of type 2 diabetes and chronic kidney disease. Join us on Monday, 27 May 2024 from 7:00 pm to 8:00 pm (AEST) as our panel of experts discuss the effects of GLP-1 agonists on renal outcomes. We will be reviewing study results presented at […]
21-24 June 2024 Join us as we bring you the latest highlights from the American Diabetes Association (ADA) 84th Scientific Sessions in Orlando, FL, USA, taking place 21-24 June 2024! The sessions that we will be focusing on: SURMOUNT-OSA Trial Results and Potential Role of Tirzepatide in Treating Obesity-Related Obstructive Sleep Apnea SELECT Trial—New Looks at […]
Join us on Thursday, 25 July 2024 from 7:00 pm to 8:00 pm (AEST) as we discuss the following in relation to the benefits of SGLT2 inhibitors in diabetes management: Role of glycaemic control Impact of glucose lowering on renal and cardiac function Where SGLT2i fit in and change the paradigm Navigating the new PBAC recommendations […]
We invite all early career ADS members to be part of the ADS Early Career Network (ECN), an ADS initiative to support clinicians and scientists with an interest in diabetes. The ADS ECN Subcommittee has developed a structure focused on four key pillars: research, education, professional development and social networking. By working collaboratively with senior […]
We are delighted to host the Australasian Diabetes Congress at the Perth Convention and Exhibition Centre, August 21 - 23, 2024. The content will once again be exceptional. The program organising committees of both societies have collaboratively developed an integrated program that will cover the latest breakthroughs in research, education and clinical care in diabetes. […]
The Australian Diabetes Society is proud to host the ADS Diabetes Technology Workshop which will be held over 1.5 days on Saturday 12 & Sunday 13 October 2024 in Melbourne at the Crowne Plaza Hotel. The workshop is primarily open to clinicians (endocrinologists or consultant physicians) who manage people living with type 1 diabetes. The aim of the workshop is to […]
Join us on Thursday, 5 December 2024 from 7:00 pm to 8:00 pm (AEDT) as we discuss the latest trials on the management of MASH in people with and without diabetes. We’ll focus on the Australian clinical context, considering GESA’s recent position statement on MAFLD screening and diagnosis as well as ADS’ provision statement on managing […]
For all enquiries:
145 Macquarie Street,
Sydney, NSW, 2000
Acknowledgement of Country
The Australian Diabetes Society acknowledges the Traditional Custodians of the lands upon which we live, learn and work.
We pay our respects to Elders both past, present and future.
Design by Aptly
